Tyrosine kinase inhibitors

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Tyrosine kinase inhibitors
Feb 4, 2025, 17:00 | Science
Bosutinib-Induced Pleural Effusion—Class Effect and Cross-Intolerance to All Tyrosine Kinase Inhibitors by Nikhil Vojjala et al.
Nikhil Vojjala, MD in Internal Medicine at Trinity Health MI, shared his recent article on…
Jan 14, 2025, 18:08 | Insight
New Research Highlight: Amivantamab With TKIs for Advanced NSCLC - ALK Positive Inc.
ALK Positive Inc. shared a post on LinkedIn: "New Research Highlight: Amivantamab With TKIs for…
Aug 8, 2024, 10:24 | Blog
Talha Badar: Advance line of TKI vs allogenic stem cell transplantation in resistant CML
Talha Badar shared a post on X: ''Treatment of resistant chronic myeloid leukemia (CML); advanced…
Jun 22, 2024, 11:43 | Blog
The language we use to describe late-stage cancer must change - EGFR Positive UK
EGFR Positive UK posted on X: "The language we use to describe late-stage cancer must…
May 8, 2024, 00:58 | Blog
Stephen V Liu: Dr. Passiglia Fra at Rome Lung 24 illustrates the limited role of immunotherapy in driver positive NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
Apr 28, 2024, 12:38 | Insight
Piotr Wysocki: Combined treatment (TKI+ICI) does not benefit favorable-risk mRCC patients
Piotr Wysocki recently shared on LinkedIn: "For several years, combined therapy based on the administration of…
Apr 11, 2024, 14:28 | Insight
New Paper Alert! Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors
Promising Results from Cabozantinib Phase 2 trial in advanced Adrenocortical Tumors  Authors: Matthew T Campbell,…
Feb 28, 2024, 12:20 | Blog
Aaron Goodman: Saw dasatinib-induced hyperthyroidism in one of my patients and was unaware this could happen
Aaron Goodman recently shared a post on X/Twitter: "Saw dasatinib-induced hyperthyroidism in one of my patients…
Nov 28, 2023, 18:00 | Drugs
Stephen V Liu: Report on real world efficacy and safety of amivantamab including off label use
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at the Lombardi Comprehensive Cancer…
All: 9 Posts: 1 - 100
Special Coverage